Most talked about Sacramento Business Journal stories

Boston company touts trial results of potentially revolutionary Type 2 diabetes treatment — Boston startup Intarcia Therapeutics Tuesday night released clinical trial results for a product that proponents say could revolutionize the treatment of Type 2 diabetes. One trial, involving hundreds of patients and placebo comparisons, produced positive results for a device developed by Intarcia called the ITCA 650.

Tampa financier raising equity for Harbour Island apartment tower — A Tampa financier with a track record of raising money for downtown projects is working to secure equity for the Harbour Island apartment tower. Harbour Island Aparments LP, under the direction of Gar Lippincott, said in a U.S. Securities and Exchange Commission filing Wednesday that it has raised $2 million of a $19 million offering.

Visterra gets $30M for flu drug as Sarepta, Alere also advance treatments — With annual flu season looming, a Cambridge biotech firm is getting a $30 million shot in the arm to develop its drug which could not only cure the disease, but prevent it. The investment into Visterra being announced today is one of several advancements of new ways to help fight influenza announced in recent days by local companies Sarepta Therapeutics and Alere.
Oct 02, 2014

#ebola has killed 2,600 this year. #flu could kill 500,000. Here's who's working on the bigger threat $SRPT $ALR…